ONC

Lai Wang

Known title: Global Head of R&DCIK: 0001852291

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

BeOne Medicines Receives Rating Upgrade and Added to Top-Rated List. BeOne Medicines Ltd. has been upgraded to a top rating by analysts. It was also added to a list of top-rated stocks for the week. The upgrade follows recent earnings and infrastructure updates discussed in a broader market analysis. The move may influence investor perception of the company.

this person other insiders at ONC

Transaction History

ONC▼ Sell$296K
ONC▼ Sell$310K
ONC▲ Buy$0
ONC▼ Sell$197K
ONC▼ Sell$357K
ONC▼ Sell$11K
ONC▲ Buy$0
ONC▲ Buy$0
ONC▲ Buy$0
ONC▼ Sell$1.8M
ONC▼ Sell$79K
ONC▼ Sell$891K
ONC▼ Sell$88K
ONC▼ Sell$243K
ONC▼ Sell$210K
ONC▼ Sell$267K
ONC▼ Sell$118K
ONC▼ Sell$314K
ONC▲ Buy$0
ONC▼ Sell$76K
ONC▼ Sell$150K
ONC▼ Sell$77K
ONC▼ Sell$51K
ONC▲ Buy$0
ONC▼ Sell$113K
ONC▼ Sell$104K
ONC▼ Sell$461K
ONC▼ Sell$338K
ONC▼ Sell$123K
ONC▼ Sell$147K
ONC▼ Sell$1.1M
ONC▼ Sell$170K
ONC▼ Sell$322
ONC▼ Sell$129K
ONC▼ Sell$76K
ONC▼ Sell$48K
ONC▼ Sell$38K
ONC▼ Sell$77K
ONC▲ Buy$0
ONC▼ Sell$201K
ONC▼ Sell$916
ONC▼ Sell$255K
ONC▲ Buy$0
ONC▼ Sell$36K
ONC▼ Sell$17K
ONC▼ Sell$25K
ONC▼ Sell$26K
ONC▼ Sell$81K
ONC▲ Buy$0
ONC▼ Sell$108K
ONC▼ Sell$62K
ONC▼ Sell$94K
ONC▲ Buy$536K
ONC▲ Buy$3.5M
ONC▲ Buy$0
ONC▼ Sell$0
ONC▼ Sell$0
ONC▼ Sell$0

We use analytics to understand how market-wall is used. No personal data is sold.